DudeDiligence.

THE WIRE

What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.

BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing

Key

BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing

Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.

  1. NKTXNkarta, IncRegulation FD disclosure and other events.−34.4%8-K 7.01 ↗
  2. TMCTMC the metals Co IncRegulation FD disclosure.−33.0%8-K 7.01 ↗
  3. SGRYSurgery Partners, IncMaterial agreement and Regulation FD disclosure.+15.4%8-K 1.01 ↗
  4. FOXAFox CorpOther events (amended).−5.6%8-K/A 8.01 ↗
  5. SGISomnigroup International IncRegulation FD disclosure.−9.9%8-K 7.01 ↗
  6. MGLDMarygold Companies, IncResults of operations.The Marygold Companies Reports Financial Results For First Fiscal Quarter Ended September 30, 20260.0%8-K 2.02 ↗
  7. IPFXInflection Point Acquisition Corp. VIRegulation FD disclosure.−0.1%8-K 7.01 ↗
  8. MANEVeradermics, IncRegulation FD disclosure and other events.−13.9%8-K 7.01 ↗
  9. KALAKALA BIO, IncResults of operations.KALA BIO Provides CEO Update and Preliminary Third Quarter 2026 Financial Results+1634.0%8-K 2.02 ↗
  10. TLSTelos CorpResults of operations.Telos Corporation Announces Third Quarter 2026 Earnings+50.6%8-K 2.02 ↗
  11. UGUnited Guardian IncResults of operations.United-Guardian Reports Higher Third Quarter Earnings+9.5%8-K 2.02 ↗
  12. CCSCentury Communities, IncOfficer or director change and Regulation FD disclosure.Headline: Century Communities Announces Promotion of Jim Francescon to President Subhead: Appointment Reflects Company’s Commitment to Long-Term Succession Planning for Top 10 Public Homebuilder−11.3%8-K 5.02 ↗
  13. CAPSCapstone Holding CorpMaterial agreement and Regulation FD disclosure.Capstone Extends Convertible Note Maturity to December 2027 Extension provides additional financial flexibility following retirement of approximately 87% of original convertible note principal.−24.2%8-K 1.01 ↗
  14. SMSM Energy CoOfficer or director change.−4.5%8-K 5.02 ↗
  15. COURCoursera, IncMaterial agreement and bylaws or fiscal year changed.Coursera Adopts Limited-Duration Stockholder Rights Plan Board of Directors Takes Action to Protect Long-Term Value for All Stockholders and Other Stakeholders in Response to a Recent Third-Party…−8.3%8-K 1.01 ↗
  16. AXGNAxogen, IncRegulation FD disclosure.+11.5%8-K 7.01 ↗
  17. WMGWarner Music Group CorpOther events.Warner Music Group Corp. Announces Quarterly Cash Dividend+4.5%8-K 8.01 ↗
  18. BMNRBitmine Immersion Technologies, IncRegulation FD disclosure.−30.8%8-K 7.01 ↗
  19. FTHFaeth Therapeutics, IncOther events.−64.3%8-K 8.01 ↗
  20. IIPRInnovative Industrial Properties IncOther events.−12.9%8-K 8.01 ↗
  21. SSNCSS&C Technologies Holdings IncMaterial agreement and unregistered sale of shares.SS&C Announces Proposed Private Placement of $1.0 Billion of Convertible Senior Notes Due 2031−4.6%8-K 1.01 ↗
  22. SONSonoco Products CoOfficer or director change and Regulation FD disclosure.Sonoco Announces CEO Succession Plan Howard Coker to Retire Following Distinguished 41-year Career, Including as Director, President and CEO since 2020 Ernest Haynes, Sonoco President of Global…−7.9%8-K 5.02 ↗
  23. FRVOFervo Energy CoResults of operations.+10.7%8-K 2.02 ↗
  24. APVOAptevo Therapeutics IncOther events.−67.4%8-K 8.01 ↗
  25. NWLNewell Brands IncOfficer or director change.Newell Brands Elects William “Bill” Newlands to Board of Directors Former President and CEO of Constellation Brands brings public company leadership and consumer brand-building experience; Board…−3.1%8-K 5.02 ↗
  26. VTGNVistagen Therapeutics, IncOther events.Vistagen Provides Regulatory Update Following Productive Type C Meeting with U.S. FDA on Phase 3 Development of Fasedienol for Social Anxiety Disorder Constructive feedback from FDA clarifies…+2.3%8-K 8.01 ↗
  27. VIRVir Biotechnology, IncRegulation FD disclosure and other events.−31.3%8-K 7.01 ↗
  28. EMPDEmpery Digital IncRegulation FD disclosure and other events.−12.3%8-K 7.01 ↗
  29. ONMDOneMedNet CorpResults of operations.OneMedNet Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap Contracted Demand Now Stands at Nearly 14 Times Full-Year 2025 Bookings…−8.6%8-K 2.02 ↗
  30. SLESuper League Enterprise, IncOther events.−24.7%8-K 8.01 ↗
  31. NGNENeurogene IncResults of operations.−12.5%8-K 2.02 ↗
  32. SHFSSHF Holdings, IncResults of operations and other events.Revenue increases 6.5% to $1.95 million, supported by 70.2% growth in loan program income Average client deposits rise to $112 million, with quarter-end trailing 14-day average deposits reaching…−88.6%8-K 2.02 ↗
  33. DFDVDeFi Development CorpOther events.DeFi Development Corp. Increases SOL Treasury to 2.61 Million Company Adds 8,881 SOL and SOL Equivalents, Marking Nine Consecutive Weeks of SOL Purchases CHAD's 14.00% annual dividend rate continues…−35.5%8-K 8.01 ↗
  34. HRTXHeron Therapeutics, IncResults of operations.Heron Therapeutics Announces Third Quarter 2026 Financial Results • Q3 2026 net revenue of $35.3 million; ZYNRELEF® net revenue up 13.8% and APONVIE® net revenue up 49.3% compared to the third…−13.8%8-K 2.02 ↗
  35. MREOMereo BioPharma Group plcResults of operations.−8.1%8-K 2.02 ↗
  36. OPALOPAL Fuels IncResults of operations.OPAL Fuels Reports Third Quarter 2026 Results−11.0%8-K 2.02 ↗
  37. QTRXQuanterix CorpResults of operations and Regulation FD disclosure.Quanterix Releases Financial Results for the Third Quarter of 2026 Reports $35.0 million in revenue, up 6.3% sequentially, and $80.7 million of cash and marketable securities Initiatives to…−32.3%8-K 2.02 ↗
  38. UNITUniti Group IncResults of operations.Release date: November 9, 2026 Uniti Group Inc. Reports Third Quarter 2026 Results Two Straight Quarters of Record Waves Bookings Raising Full Year Revenue Guidance • Net Loss of $244.5 Million for…−32.0%8-K 2.02 ↗
  39. ADCTADC Therapeutics SAResults of operations.−19.0%8-K 2.02 ↗
  40. LKQLKQ CorpOfficer or director change.Salvatore Abbate to Assume Role of LKQ President and CEO on November 9, 2026−6.2%8-K 5.02 ↗
  41. JSPRJasper Therapeutics, IncOther events.−48.5%8-K 8.01 ↗
  42. SPRBSpruce Biosciences, IncResults of operations.−18.4%8-K 2.02 ↗
  43. INMInMed Pharmaceuticals IncRegulation FD disclosure.+27.7%8-K 7.01 ↗
  44. WHWKWhitehawk Therapeutics, IncResults of operations.−1.9%8-K 2.02 ↗
  45. EVLVEvolv Technologies Holdings, IncOfficer or director change and Regulation FD disclosure.Evolv Technology Announces the Appointment of Jason Blessing as a New Independent Director - Former Public Company CEO Brings More Than 30 Years of Leadership Experience at Technology-Based Businesses−16.8%8-K 5.02 ↗
  46. DCTHDelcath Systems, IncResults of operations.Delcath Systems Reports Third Quarter 2026 Results and Business Highlights Increases 2026 Revenue Guidance to a Range of $115 million to $117 million Conference Call Today at 8:30 a.m. Eastern Time+25.9%8-K 2.02 ↗
  47. RBARB Global IncResults of operations and other events.RB Global reports third quarter 2026 results−2.5%8-K 2.02 ↗
  48. CNHCNH Industrial N.V.Material agreement and Regulation FD disclosure.Transaction values CNH’s Construction Equipment business at an enterprise value of $1 billion; CNH to receive cash and 30% ownership in the joint venture; transaction expected to be accretive to CNH…−7.1%8-K 1.01 ↗
  49. TPBTurning Point Brands, IncResults of operations.Reaffirming FY 2026 Modern Oral Gross and Net Sales and EBITDA guidance−29.6%8-K 2.02 ↗
  50. QNMEQuanome Technologies, IncMaterial agreement and unregistered sale of shares.−35.4%8-K 1.01 ↗